Genetics

CRISPR: A licence to heal

As all sides prepare for a milestone case in the battle over rights to CRISPR/Cas9, LSIPR’s Rory O’Neill finds the CEO of ERS Genomics in a positive mood.

• Brexit: The waiting game 01-10-2019
• IP portfolios: the five biggest headaches for in-house counsel 30-09-2019
• Genetic research: DNA payday 30-09-2019
• CRISPR: Hearing all about it 30-09-2019
• The future of precision medicine part 7: public engagement 29-08-2019

More genetics features